白藜蘆醇調(diào)控內(nèi)皮細(xì)胞凋亡及促血栓分子P-Selectin、vWF表達(dá)的實(shí)驗(yàn)研究
[Abstract]:DVT is a common clinical complication after large-size orthopedic surgery, and it is one of the important causes of the perioperative death in the patients with venous reflux disease, high incidence and high risk. The pathogenesis of the DVT is complicated, and it is related to the factors such as endothelial cell, platelet, and white blood cell. In recent years, the research has shown that the damage of the vascular endothelial cells is one of the most important reasons for venous thrombosis, and the endothelial cells can release various adhesion molecules and platelet activating factors after the endothelial cells are damaged. the tissue factor, the enhanced blood coagulation and the promotion of the formation of the DVT; however, the oxidative stress reaction, the inflammatory reaction is a common cause of the damage of the vein endothelial cells, the oxidative stress and the inflammation can cause the active oxygen and the inflammation factor of the organism to increase, and the lipid peroxidation and the NO of the cells are reduced, so as to cause injury and apoptosis of the endothelial cells and promote the formation of the DVT; at the same time, the research shows that the NF-B can increase the expression of the tissue factor and promote the coagulation, thereby affecting the formation of the DVT, The function of protecting endothelial cell damage, however, is rare in the formation of DVT. Therefore, the purpose of this study is to study the effect of the white and aloe on the oxidative damage and apoptosis of the endothelial cells, as well as the effect of the expression of P-Selectin and vWF on the thrombogenic molecules. [Objective] 1. Objective To study the effect of the white-and-white aloe on the oxidative damage and apoptosis of the endothelial cells. To study the effect and regulation mechanism of the expression of P-Selectin and vWF on the endothelial cells after the injury of the endothelial cells. [Method] This study is divided into two parts:1. The first part, this experiment part was divided into three groups: (1) blank control group; (2) H202 group: human umbilical vein endothelial cells were treated with 20. mu. mo/ L H202 for 24 hours to establish a model of vein endothelial cell damage; (3) RES + H2O2 group: after the HUVECs were pre-treated with 30. m The cells were treated with 200. m u.M/ L of H202 for 24 hours. The activity of the cells in each group was detected by MTT method, and the protective effect of the white and aloe on the H202-induced HUVECs injury was discussed. The content of reactive oxygen ROS in the cells was detected by using the fluorescence probe DCFH-DA capture method and the laser confocal microscope. Hoechst 33258 staining, fluorescence microscope, Annexin V-FITC/ PI double staining method and flow cytometry were used to detect the apoptosis of the cells. The second part, this experiment part is divided into four groups; (1) blank control group; (2) H202 group: this group is the same as the first part; (3) RES + H2O2 group: this group is the same as the first part; (4) BAY11-7082 + H2O2 group: after 4 hours of pretreatment of BAY 11-7082 with 5. m The cells were incubated with 200. m u.mol/ L of H2O2 for 24 hours. Using Real-Time PCR and western blot, the expression of NF-B, P-Selectin, vWF and protein in each group were detected, and the effect and regulation mechanism of the expression of P-Selectin and vWF on the endothelial cells after the injury of the endothelial cells were discussed. [Results] 1. The results of the first part showed that the cell viability of HUVECs was significantly lower than that of the control group (P0.01). The content of ROS in the cells increased significantly (P0.01), and the rate of apoptosis was significantly increased (P0.01). However, after the pretreatment of HUVECs by 30 & mu; mo/ L, the cells were incubated with 200 & mu; mo/ L H202 for 24 hours, that is, the RES + H2O2 group, and the activity of the cells was significantly higher than that of the H202 group (P0.01). The content of ROS in the cells was significantly decreased (P0.01), and the apoptosis rate of the cells was significantly decreased (P0.01). The results of the second part: (1) After the treatment of HUVECs for 24 hours with 200 & mu; mol/ L H202, the expression of NF-B, P-Selectin, vWFmRNA and protein in the H202 group was significantly higher than that in the control group (P0.01). (2) After the pretreatment of BAY 11-7082 5umol/ L, the specific inhibitor BAY 11-7082 5 & mu; mol/ L was treated with 200 & mu; mol/ L H _ 2O _ 2 for 24 hours, that is, BAY11-7082 + H2O2 group, and the expression of NF-BmRNA and protein of BAY11-7082 + H2O2 group was down-regulated (P0.01), P-Selectin, The expression of vWFmRNA and protein was also down-regulated (P0.05). (3) After the pre-treatment of 30. m u.mol/ L of Phragon for 2 hours, the cells were treated with 200. m u.mol/ L H _ 2O _ 2 for 24 hours, that is, the RES + H2O2 group, and the expression of NF-BmRNA and protein in the group was down-regulated (P0.01), and the expression of P-Selectin, vWFmRNA and protein was also down-regulated (P0.05). (4) Compared with BAY 11-7082 + H2O2 group, the expression of NF-EMAB mRNA and protein in BAY 11-7082 + H2O2 group was lower than that of BAY 11-7082 + H2O2 group (P0.01). [Conclusion] 1. Phragon can reduce the damage and apoptosis of the endothelial cells. 3. NF-EMAB was involved in the expression of P-Selectin and vWF after endothelial cell injury. It can inhibit the activation of P-Selectin and vWF, and may play an important role in the formation of DVT.
【學(xué)位授予單位】:昆明醫(yī)科大學(xué)
【學(xué)位級(jí)別】:碩士
【學(xué)位授予年份】:2017
【分類號(hào)】:R68
【參考文獻(xiàn)】
相關(guān)期刊論文 前10條
1 婁振凱;羅旺;李興國(guó);趙學(xué)凌;王兵;;H_2O_2、LPS和TNF-α誘導(dǎo)人類臍靜脈內(nèi)皮細(xì)胞損傷的實(shí)驗(yàn)研究[J];國(guó)際骨科學(xué)雜志;2015年03期
2 李上標(biāo);裴淑艷;蔣超;馬玉;郭忠;;MTT比色法研究應(yīng)用進(jìn)展[J];西北民族大學(xué)學(xué)報(bào)(自然科學(xué)版);2013年03期
3 曲柳;仇麗鴻;;SIRT1抑制炎癥反應(yīng)的研究進(jìn)展[J];中國(guó)實(shí)用口腔科雜志;2013年09期
4 劉永剛;羅景慧;;白藜蘆醇對(duì)過(guò)氧化氫誘導(dǎo)的人臍靜脈血管內(nèi)皮細(xì)胞損傷的保護(hù)作用[J];中成藥;2011年07期
5 龐興學(xué);王顯;;血栓形成的過(guò)程與機(jī)制研究進(jìn)展[J];醫(yī)學(xué)綜述;2011年11期
6 閆啟光;;白藜蘆醇抗血栓作用實(shí)驗(yàn)研究[J];中國(guó)民族民間醫(yī)藥;2010年13期
7 邱貴興;;中國(guó)骨科大手術(shù)靜脈血栓栓塞癥預(yù)防指南[J];中華關(guān)節(jié)外科雜志(電子版);2009年03期
8 韓晶晶;劉煒;畢玉平;;白藜蘆醇的研究進(jìn)展[J];生物工程學(xué)報(bào);2008年11期
9 戴群;劉惠敏;;白藜蘆醇及其生理功能[J];江蘇教育學(xué)院學(xué)報(bào)(自然科學(xué)版);2006年03期
10 付研;王大為;;血栓栓塞性疾病的急診治療和預(yù)防(1)[J];中國(guó)臨床醫(yī)生;2006年08期
,本文編號(hào):2507590
本文鏈接:http://sikaile.net/yixuelunwen/waikelunwen/2507590.html